Pharmacological approaches to treating addiction are evolving rapidly, with growing evidence supporting the efficacy of medication-assisted interventions for diverse substances. Pharmacotherapy and medication-assisted treatment have transformed recovery trajectories for individuals struggling with opioids, alcohol, and even nicotine. Agents like buprenorphine, methadone, and naltrexone help mitigate withdrawal symptoms and reduce cravings while stabilizing long-term outcomes. Integration of behavioral support enhances the efficacy of these medications, providing a more comprehensive care pathway. Clinicians now focus on individualized treatment planning, ensuring the right pharmacological support is matched with the patient's physiological and psychological needs. As stigma diminishes, accessibility and adherence rates continue to improve.
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : PIVOT: Predictive intervention for vaping using resonance modeling of oscillatory, psychological, and trigger dynamics
Aadya, Issaquah High School, United States
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College, United States
Title : Addiction and the failure of meaning-forming
Jenni Guentcheva, GTI, United States
Title : What to do when a tragedy strikes
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Reward deficiency syndrome solution patient claims ‘dopamine homeostasis’ provided the neurological stability to begin focusing upon healing psychic fracture associated with chronic post-traumatic stress disorder dissociative multiplicity
Elizabeth Dale Gilley, The Elle Foundation, United States